Clinical Trial Update: A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood [Phase 1]

View source ↗

Summary

A Phase 1 study in women with overweight or obesity evaluates whether different doses of BI 456906 alter the blood levels of a contraceptive to assess potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BI 456906

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED